These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 22227116)

  • 21. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate generation for endonucleases of CRISPR/cas systems.
    Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage.
    Wang R; Preamplume G; Terns MP; Terns RM; Li H
    Structure; 2011 Feb; 19(2):257-64. PubMed ID: 21300293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi: prokaryotes get in on the act.
    van der Oost J; Brouns SJ
    Cell; 2009 Nov; 139(5):863-5. PubMed ID: 19945373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
    Charpentier E; Richter H; van der Oost J; White MF
    FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
    Zhu X; Ye K
    Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.
    Peng W; Feng M; Feng X; Liang YX; She Q
    Nucleic Acids Res; 2015 Jan; 43(1):406-17. PubMed ID: 25505143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
    Cooper LA; Stringer AM; Wade JT
    mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus.
    Carte J; Christopher RT; Smith JT; Olson S; Barrangou R; Moineau S; Glover CV; Graveley BR; Terns RM; Terns MP
    Mol Microbiol; 2014 Jul; 93(1):98-112. PubMed ID: 24811454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex.
    Ramia NF; Spilman M; Tang L; Shao Y; Elmore J; Hale C; Cocozaki A; Bhattacharya N; Terns RM; Terns MP; Li H; Stagg SM
    Cell Rep; 2014 Dec; 9(5):1610-1617. PubMed ID: 25482566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR transcript processing: a mechanism for generating a large number of small interfering RNAs.
    Djordjevic M; Djordjevic M; Severinov K
    Biol Direct; 2012 Jul; 7():24. PubMed ID: 22849651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primed CRISPR DNA uptake in Pyrococcus furiosus.
    Garrett S; Shiimori M; Watts EA; Clark L; Graveley BR; Terns MP
    Nucleic Acids Res; 2020 Jun; 48(11):6120-6135. PubMed ID: 32421777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA.
    Li Y; Zhang Y; Lin J; Pan S; Han W; Peng N; Liang YX; She Q
    Nucleic Acids Res; 2017 Nov; 45(19):11305-11314. PubMed ID: 28977458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.
    Pan S; Li Q; Deng L; Jiang S; Jin X; Peng N; Liang Y; She Q; Li Y
    RNA Biol; 2019 Sep; 16(9):1166-1178. PubMed ID: 31096876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prokaryotic RNAi.
    Rusk N
    Nat Methods; 2012 Mar; 9(3):220-1. PubMed ID: 22479705
    [No Abstract]   [Full Text] [Related]  

  • 37. Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III.
    Nickel L; Weidenbach K; Jäger D; Backofen R; Lange SJ; Heidrich N; Schmitz RA
    RNA Biol; 2013 May; 10(5):779-91. PubMed ID: 23619576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding and cleavage of CRISPR RNA by Cas6.
    Carte J; Pfister NT; Compton MM; Terns RM; Terns MP
    RNA; 2010 Nov; 16(11):2181-8. PubMed ID: 20884784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
    Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
    RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
    Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
    Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.